Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Inducing Chimeric Antigen Receptor (Car) Regulatory T Cells In-Vivo: A Novel Concept for a Potential Feasible Cure of Demyelinating Diseases Publisher Pubmed



Sedaghat N1 ; Etemadifar M2
Authors

Source: Multiple Sclerosis and Related Disorders Published:2022


Abstract

Chimeric antigen receptor (CAR) regulatory T cell (Treg) therapy has approved promising in murine experiments. It comprises from ex-vivo introduction of CARs to the Tregs of the recipient, and infusing them back thereafter. This process requires enormous amounts of equipment and expertise and therefore, cannot be considered feasible for people with demyelinating diseases, even if it proves to be effective and safe in the future. The presented novel concept introduces feasibility to CAR Treg therapy, by shifting most of the ex-vivo processes in-vivo. Inter-disciplinary discussions on such concepts is encouraged among experts in different fields. © 2021 Elsevier B.V.
Related Docs
View other Related Docs
1. An Updated Overview of the Application of Car-T Cell Therapy in Neurological Diseases, Biotechnology Progress (2023)
2. Chimeric Antigen Receptor-T Cells Immunotherapy for Targeting Breast Cancer, Research in Pharmaceutical Sciences (2021)
3. A Novel Car Expressing Nk Cell Targeting Cd25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers, Frontiers in Oncology (2021)
Experts (# of related papers)
View all Related Experts
Abbas Rezaei (2)
Nafiseh Esmaeil (1)
Other Related Docs
4. The Effects of Silymarin and Cyclosporine a on the Proliferation and Cytokine Production of Regulatory T Cells, Immunological Investigations (2019)
5. Evaluation of Soluble Human Leukocyte Antigen-G (Shla-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2015)
6. Restoring Immune Balance With Tregitopes: A New Approach to Treating Immunological Disorders, Biomedicine and Pharmacotherapy (2024)
7. Regulating the Regulatory T Cells As Cell Therapies in Autoimmunity and Cancer, Frontiers in Medicine (2023)
8. In Vitro Selective Depletion of Cd4+Cd25+ Regulatory T-Cells From Pbmc Using Anti-Tac-Sap, Journal of Immunotoxicology (2012)
9. Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers, Anti-Cancer Agents in Medicinal Chemistry (2025)
10. Gene-Knocked Out Chimeric Antigen Receptor (Car) T Cells: Tuning up for the Next Generation Cancer Immunotherapy, Cancer Letters (2018)